⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Halozyme Therapeutics, Inc.

$99.48
-1.19 (-1.18%)

Volume:

2.27M ($227.24M)

Market Capitalization:

$11.34B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Halozyme Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

-0.79(-0.79%)
Open$100.27
Close$99.48
Low$99.48
Low Change-0.79 (-0.79%)
High$100.28
High Change+0.01 (+0.01%)
Range$0.80
Volume328.952K
Dollar Volume$32.72M

Regular Trading Hours

-0.44(-0.44%)
Open$100.66
Close$100.22
Low$99.26
Low Change-1.40 (-1.39%)
High$101.23
High Change+0.57 (+0.56%)
Range$1.97
Volume1.939M
Dollar Volume$194.38M

Premarket

+0.00(+0.00%)
Open$100.66
Close$100.66
Low$100.66
Low Change0.00 (0.00%)
High$100.78
High Change+0.12 (+0.12%)
Range$0.12
Volume1.416K
Dollar Volume$142.53K

After Hours Yesterday

-0.13(-0.13%)
Open$100.67
Close$100.54
Low$100.54
Low Change-0.13 (-0.13%)
High$100.67
High Change+0.00 (+0.00%)
Range$0.13
Volume351.007K
Dollar Volume$35.29M

Regular Trading Hours Yesterday

-0.91(-0.90%)
Open$101.58
Close$100.67
Low$100.27
Low Change-1.31 (-1.29%)
High$102.14
High Change+0.56 (+0.55%)
Range$1.87
Volume1.066M
Dollar Volume$107.27M

Premarket Yesterday

+0.00(+0.00%)
Open$101.78
Close$101.78
Low$101.78
Low Change0.00 (0.00%)
High$101.78
High Change+0.00 (+0.00%)
Range$0.00
Volume173
Dollar Volume$17.61K

Halozyme Therapeutics Top Trades

Halozyme Therapeutics's top trade so far today returned +1.03%, while the top short trade returned -1.72%.

Halozyme Therapeutics Moving Averages

5 Day Moving Average (SMA5)$102.41
10 Day Moving Average (SMA10)$115.37
20 Day Moving Average (SMA20)$120.76
50 Day Moving Average (SMA50)$114.78
100 Day Moving Average (SMA100)$101.95
200 Day Moving Average (SMA200)$85.30

Halozyme Therapeutics Statistics

Average Volume (30 Days)2.35M
P/E Ratio (Current)23.87
EPS (Current)$4.26
Dividend Yield0.00%
Free Cash Flow$885.88M
Cash Ratio2.16
Current Ratio3.88
Quick Ratio3.60
Debt to Equity-58.84
Enterprise Value$13.81B
EV to EBITDA12.15
EV to Sales7.66
Price to Book-209.86
Price to Cash Flow12.91
Price to Free Cash Flow13.09
Price to Sales6.43
Return on Assets0.14%
Return on Equity-8.79%

Halozyme Therapeutics Stock Splits

There have been no stock splits for Halozyme Therapeutics (HALO).

Halozyme Therapeutics Dividends

There have been no dividends for Halozyme Therapeutics (HALO).